Aspen Aerogels, Inc. achieved record revenues of $123.1 million in Q4 2024, a 46% year-over-year increase, with net income reaching $11.4 million and Adjusted EBITDA at $22.7 million, demonstrating strong operational performance and profitability.
Record Company revenues of $123.1 million, up 46% year-over-year.
Net income of $11.4 million, an $11.9 million improvement year-over-year.
Adjusted EBITDA of $22.7 million, a $13.6 million or 149% improvement year-over-year.
Cash generated from operations of $35.7 million in the quarter drove $20.9 million of free cash flow.
For Q1 2025, Aspen expects revenue to range between $75 million and $95 million, with a net loss between $15.0 million and breakeven, and Adjusted EBITDA between breakeven and $15 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance